Allergan Sues Hi-Tech To Block Generic Lash Drug Latisse
Allergan Inc. filed its third patent infringement suit against Hi-Tech Pharmacal Co. Inc. in North Carolina federal court on Wednesday, its latest effort to block a generic version of the eyelash...To view the full article, register now.
Already a subscriber? Click here to view full article